Health Affairs, 26, no. 5 (2007): 1392-1398 doi: 10.1377/hlthaff.26.5.1392 © 2007 by Project HOPE	New Online   New Issue: China & India   Obesity In China   Pay Cuts For Medicare Docs   Access To Care Woes

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kallen, A. Articles by Schwartz, L. Search for Related Content PubMed PubMed Citation Articles by Kallen, A. Articles by Schwartz, L. Related Collections AIDS/HIV Business Of Health Consumer Issues Ethical Issues Legal/Regulatory Issues Pharmaceuticals

Health Tracking

MARKETWATCH

Direct-To-Consumer Advertisements For HIV Antiretroviral Medications: A Progress Report

Direct-to-consumer (DTC) prescription drug advertisements for HIV anti-retrovirals are controversial and have been criticized in the past for including deceptive images and underplaying HIV drug limitations. We sought to describe the state of recent DTC ads for HIV antiretrovirals in popular magazines by performing a content analysis of all complete DTC ads for antiretroviral medications appearing in eight national magazines during a one-year period. Current ads appear to have addressed previous concerns, but important problems still exist, such as failing to specify the medication’s role in current treatment, to quantify drug efficacy, or to highlight life-threatening side effects.

                      What's this?